Skip to main content
Erschienen in: Journal of Neurology 6/2009

01.06.2009 | Original Communication

In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer’s disease

verfasst von: Giovanni B. Frisoni, Annapaola Prestia, Paul E. Rasser, Matteo Bonetti, Paul M. Thompson

Erschienen in: Journal of Neurology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Progressive brain atrophy is believed to be the Alzheimer’s disease (AD) marker with the greatest evidence for validity. Mapping the topography of cortical atrophy throughout the stages of severity may allow the neural networks affected to be identified. Twenty healthy elderly persons (OH, MMSE 29.1 ± 1.0), 11 patients with incipient AD (iAD, 26.5 ± 2.0), 15 with mild AD (miAD, 23.5 ± 2.2), and 15 with moderate AD (moAD, 16.5 ± 2.0) underwent 3D magnetic resonance. Cortical pattern matching analysis was performed and maps of percent differences in gray matter distribution were computed between the following groups: iAD versus OH, miAD versus iAD, and moAD versus miAD. Compared to OH, iAD patients exhibited a mean cortical gray matter loss of 9–20% in areas encompassing the polysynaptic hippocampal pathway (posterior cingulate/retrosplenial and medial temporal cortex) and subgenual/orbitofrontal cortices, and a less widespread loss of 5–11% in other neocortical areas. Compared to iAD, miAD featured widespread mean gray matter loss of 14–19% in areas encompassing the direct hippocampal pathway (temporal pole, temporoparietal association cortex, and dorsal prefrontal cortex), sensorimotor, and visual cortex, with a less marked loss (7–9%) in the polysynaptic pathway areas. Compared to miAD, only atrophy in the primary sensorimotor cortex was still relatively marked in moAD, with a mean gray matter loss of 10–11%; the loss in other regions was generally below 10%. These findings suggest that the polysynaptic hippocampal pathway is affected in iAD, the direct pathway and sensorimotor and visual networks are affected in moAD, and the sensorimotor network is affected in moAD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Committee for Medicinal Products for Human Use (CHMP) (2007) Guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias (draft; CPMP/EWP/553/95 Rev. 1). CHMP, London Committee for Medicinal Products for Human Use (CHMP) (2007) Guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias (draft; CPMP/EWP/553/95 Rev. 1). CHMP, London
2.
Zurück zum Zitat Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006) Tracking atrophy progression in familial Alzheimer’s disease: a serial MRI study. Lancet Neurol 5:828–834PubMedCrossRef Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006) Tracking atrophy progression in familial Alzheimer’s disease: a serial MRI study. Lancet Neurol 5:828–834PubMedCrossRef
3.
Zurück zum Zitat Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2008) MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 70:512–520PubMedCrossRef Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2008) MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 70:512–520PubMedCrossRef
4.
Zurück zum Zitat Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW (2003) Dynamics of gray matter loss in Alzheimer’s disease. J Neurosci 23:994–1005PubMed Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW (2003) Dynamics of gray matter loss in Alzheimer’s disease. J Neurosci 23:994–1005PubMed
5.
Zurück zum Zitat Smith AD (2002) Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci USA 99:4135–4137PubMedCrossRef Smith AD (2002) Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci USA 99:4135–4137PubMedCrossRef
6.
Zurück zum Zitat Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease. Brain 130:1777–1786PubMedCrossRef Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease. Brain 130:1777–1786PubMedCrossRef
7.
Zurück zum Zitat Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW (2001) Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 71:441–447PubMedCrossRef Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, Yaffe K, Kramer JH, Reed B, Norman D, Chui HC, Weiner MW (2001) Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 71:441–447PubMedCrossRef
8.
Zurück zum Zitat Chételat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC (2002) Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 13:1939–1943PubMedCrossRef Chételat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC (2002) Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 13:1939–1943PubMedCrossRef
9.
Zurück zum Zitat Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winbald B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985–1992PubMedCrossRef Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winbald B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985–1992PubMedCrossRef
10.
Zurück zum Zitat Lezak M, Howieson D, Loring DW (2004) Neuropsychological assessment, 4th edn. University Press, Oxford Lezak M, Howieson D, Loring DW (2004) Neuropsychological assessment, 4th edn. University Press, Oxford
11.
Zurück zum Zitat Prestia A, Rossi R, Geroldi C, Galluzzi S, Ettori M, Alaimo G, Frisoni GB (2006) Validation study of the three-objects-three-places test: a screening test for Alzheimer’s disease. Exp Aging Res 32:395–410PubMedCrossRef Prestia A, Rossi R, Geroldi C, Galluzzi S, Ettori M, Alaimo G, Frisoni GB (2006) Validation study of the three-objects-three-places test: a screening test for Alzheimer’s disease. Exp Aging Res 32:395–410PubMedCrossRef
12.
Zurück zum Zitat McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMed
13.
Zurück zum Zitat Riello R, Sabattoli F, Beltramello A, Bonetti M, Bono G, Falini A, Magnani G, Minonzio G, Piovan E, Alaimo G, Ettori M, Galluzzi S, Locatelli E, Noiszewska M, Testa C, Frisoni GB (2005) Brain volumes in healthy adults aged 40 years and over: a voxel-based morphometry study. Aging Clin Exp Res 17:329–336PubMed Riello R, Sabattoli F, Beltramello A, Bonetti M, Bono G, Falini A, Magnani G, Minonzio G, Piovan E, Alaimo G, Ettori M, Galluzzi S, Locatelli E, Noiszewska M, Testa C, Frisoni GB (2005) Brain volumes in healthy adults aged 40 years and over: a voxel-based morphometry study. Aging Clin Exp Res 17:329–336PubMed
14.
Zurück zum Zitat Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW (2004) Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22(4):1754–1766; erratum (2007) 36:1397–1398 Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW (2004) Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22(4):1754–1766; erratum (2007) 36:1397–1398
15.
Zurück zum Zitat Heilbrun MP, Koehler S, MacDonald P, Siemionow V, Peters W (1994) Preliminary experience using an optimized three-point transformation algorithm for spatial registration of coordinate systems: a method of noninvasive localization using frame-based stereotactic guidance systems. J Neurosurg 81:676–682PubMedCrossRef Heilbrun MP, Koehler S, MacDonald P, Siemionow V, Peters W (1994) Preliminary experience using an optimized three-point transformation algorithm for spatial registration of coordinate systems: a method of noninvasive localization using frame-based stereotactic guidance systems. J Neurosurg 81:676–682PubMedCrossRef
16.
Zurück zum Zitat Sowell ER, Thompson PM, Rex D, Kornsand D, Tessner KD, Jernigan TL, Toga AW (2001) Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation. J Neurosci 21:8819–8829PubMed Sowell ER, Thompson PM, Rex D, Kornsand D, Tessner KD, Jernigan TL, Toga AW (2001) Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation. J Neurosci 21:8819–8829PubMed
17.
Zurück zum Zitat Thompson PM, Woods RP, Mega MS, Toga AW (2000) Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain. Hum Brain Mapp 9:81–92PubMedCrossRef Thompson PM, Woods RP, Mega MS, Toga AW (2000) Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain. Hum Brain Mapp 9:81–92PubMedCrossRef
18.
Zurück zum Zitat Shattuck DW, Leahy RM (2001) Automated graph-based analysis and correction of cortical volume topology. IEEE Trans Med Imaging 20:1167–1177PubMedCrossRef Shattuck DW, Leahy RM (2001) Automated graph-based analysis and correction of cortical volume topology. IEEE Trans Med Imaging 20:1167–1177PubMedCrossRef
19.
Zurück zum Zitat Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW (2004) Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci 24:8223–8231PubMedCrossRef Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW (2004) Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci 24:8223–8231PubMedCrossRef
20.
Zurück zum Zitat Rasser PE, Johnston P, Lagopoulos J, Ward P, Schall U, Thienel R, Bender S, Toga A, Thompson PM, Functional MRI (2005) BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage 26:941–951PubMedCrossRef Rasser PE, Johnston P, Lagopoulos J, Ward P, Schall U, Thienel R, Bender S, Toga A, Thompson PM, Functional MRI (2005) BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage 26:941–951PubMedCrossRef
21.
Zurück zum Zitat Van Essen DC (2002) Windows on the brain. The emerging role of atlases and databases in neuroscience. Curr Opin Neurobiol 12:574–579PubMedCrossRef Van Essen DC (2002) Windows on the brain. The emerging role of atlases and databases in neuroscience. Curr Opin Neurobiol 12:574–579PubMedCrossRef
22.
Zurück zum Zitat Duvernoy HM (1998) The human hippocampus: functional anatomy, vascularization and serial sections with MRI. Springer, New York, pp 29–30 Duvernoy HM (1998) The human hippocampus: functional anatomy, vascularization and serial sections with MRI. Springer, New York, pp 29–30
23.
Zurück zum Zitat Yousem DM, Williams SC, Howard RO, Andrew C, Simmons A, Allin M, Geckle RJ, Suskind D, Bullmore ET, Brammer MJ, Doty RL (1997) Functional MR imaging during odor stimulation: preliminary data. Radiology 204:833–838PubMed Yousem DM, Williams SC, Howard RO, Andrew C, Simmons A, Allin M, Geckle RJ, Suskind D, Bullmore ET, Brammer MJ, Doty RL (1997) Functional MR imaging during odor stimulation: preliminary data. Radiology 204:833–838PubMed
24.
Zurück zum Zitat Chételat G, Landeau B, Eustache F, Mézenge F, Viader F, de la Sayette V, Desgranges B, Baron JC (2005) Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 27:934–946PubMedCrossRef Chételat G, Landeau B, Eustache F, Mézenge F, Viader F, de la Sayette V, Desgranges B, Baron JC (2005) Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 27:934–946PubMedCrossRef
25.
Zurück zum Zitat Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 29:693–706PubMedCrossRef Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 29:693–706PubMedCrossRef
26.
Zurück zum Zitat Salat DH, Kaye JA, Janowsky JS (2001) Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol 58:1403–1408PubMedCrossRef Salat DH, Kaye JA, Janowsky JS (2001) Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol 58:1403–1408PubMedCrossRef
27.
Zurück zum Zitat Resnick SM, Lamar M, Driscoll I (2007) Vulnerability of the orbitofrontal cortex to age-associated structural and functional brain changes. Ann N Y Acad Sci 1121:562–575PubMedCrossRef Resnick SM, Lamar M, Driscoll I (2007) Vulnerability of the orbitofrontal cortex to age-associated structural and functional brain changes. Ann N Y Acad Sci 1121:562–575PubMedCrossRef
28.
Zurück zum Zitat Callen DJ, Black SE, Caldwell CB, Grady CL (2004) The influence of sex on limbic volume and perfusion in AD. Neurobiol Aging 25:761–770PubMedCrossRef Callen DJ, Black SE, Caldwell CB, Grady CL (2004) The influence of sex on limbic volume and perfusion in AD. Neurobiol Aging 25:761–770PubMedCrossRef
29.
Zurück zum Zitat Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33:403–408PubMedCrossRef Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33:403–408PubMedCrossRef
30.
Zurück zum Zitat Kuljis RO, Tikoo RK (1997) Discontinuous distribution of senile plaques within striate cortex hypercolumns in Alzheimer’s disease. Vision Res 37:3573–3591PubMedCrossRef Kuljis RO, Tikoo RK (1997) Discontinuous distribution of senile plaques within striate cortex hypercolumns in Alzheimer’s disease. Vision Res 37:3573–3591PubMedCrossRef
31.
Zurück zum Zitat Suvà D, Favre I, Kraftsik R, Esteban M, Lobrinus A, Miklossy J (1999) Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 58:1125–1134PubMedCrossRef Suvà D, Favre I, Kraftsik R, Esteban M, Lobrinus A, Miklossy J (1999) Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 58:1125–1134PubMedCrossRef
32.
Zurück zum Zitat Cronin-Golomb A, Rizzo JF, Corkin S, Growdon JH (1991) Visual function in Alzheimer’s disease and normal aging. Ann N Y Acad Sci 640:28–35PubMed Cronin-Golomb A, Rizzo JF, Corkin S, Growdon JH (1991) Visual function in Alzheimer’s disease and normal aging. Ann N Y Acad Sci 640:28–35PubMed
33.
Zurück zum Zitat Perretti A, Grossi D, Fragassi N, Lanzillo B, Nolano M, Pisacreta AI, Caruso G, Santoro L (1996) Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease. J Neurol Sci 135:31–37PubMedCrossRef Perretti A, Grossi D, Fragassi N, Lanzillo B, Nolano M, Pisacreta AI, Caruso G, Santoro L (1996) Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease. J Neurol Sci 135:31–37PubMedCrossRef
34.
Zurück zum Zitat Ferreri F, Pauri F, Pasqualetti P, Fini R, Dal Forno G, Rossini PM (2003) Motor cortex excitability in Alzheimer’s disease: a transcranial magnetic stimulation study. Ann Neurol 53:102–108PubMedCrossRef Ferreri F, Pauri F, Pasqualetti P, Fini R, Dal Forno G, Rossini PM (2003) Motor cortex excitability in Alzheimer’s disease: a transcranial magnetic stimulation study. Ann Neurol 53:102–108PubMedCrossRef
35.
Zurück zum Zitat Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC (2005) Focal decline of cortical thickness in Alzheimer’s disease identified by computational neuroanatomy. Cereb Cortex 15:995–1001PubMedCrossRef Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC (2005) Focal decline of cortical thickness in Alzheimer’s disease identified by computational neuroanatomy. Cereb Cortex 15:995–1001PubMedCrossRef
36.
Zurück zum Zitat Double KL, Halliday GM, Kril JJ, Harasty JA, Cullen K, Brooks WS, Creasey H, Broe GA (1996) Topography of brain atrophy during normal aging and Alzheimer’s disease. Neurobiol Aging 17:513–521PubMedCrossRef Double KL, Halliday GM, Kril JJ, Harasty JA, Cullen K, Brooks WS, Creasey H, Broe GA (1996) Topography of brain atrophy during normal aging and Alzheimer’s disease. Neurobiol Aging 17:513–521PubMedCrossRef
37.
Zurück zum Zitat Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M, AN1792(QS-21)-201 Study (2005) Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64:1563–1572PubMedCrossRef Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M, AN1792(QS-21)-201 Study (2005) Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64:1563–1572PubMedCrossRef
38.
Zurück zum Zitat Hock C, Nitsch RM (2005) Clinical observations with AN-1792 using TAPIR analyses. Neurodegener Dis 2:273–276PubMedCrossRef Hock C, Nitsch RM (2005) Clinical observations with AN-1792 using TAPIR analyses. Neurodegener Dis 2:273–276PubMedCrossRef
39.
Zurück zum Zitat Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99:4703–4707PubMedCrossRef Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99:4703–4707PubMedCrossRef
40.
Zurück zum Zitat Pakkenberg B, Gundersen HJ (1997) Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384:312–320PubMedCrossRef Pakkenberg B, Gundersen HJ (1997) Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384:312–320PubMedCrossRef
41.
Zurück zum Zitat Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M et al (2007) The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain 130:720–730PubMedCrossRef Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M et al (2007) The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain 130:720–730PubMedCrossRef
42.
Zurück zum Zitat Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L (2005) Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 1:55–66PubMedCrossRef Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L (2005) Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 1:55–66PubMedCrossRef
Metadaten
Titel
In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer’s disease
verfasst von
Giovanni B. Frisoni
Annapaola Prestia
Paul E. Rasser
Matteo Bonetti
Paul M. Thompson
Publikationsdatum
01.06.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 6/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5040-7

Weitere Artikel der Ausgabe 6/2009

Journal of Neurology 6/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.